Unrecognized Tax Benefits of CRISPR Therapeutics AG from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
CRISPR Therapeutics AG quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • CRISPR Therapeutics AG Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $50,709,000, a 1.5% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

CRISPR Therapeutics AG Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $50,709,000 +$750,000 +1.5% 31 Dec 2025 10-K 12 Feb 2026 2025 FY
Q4 2024 $49,959,000 +$5,811,000 +13% 31 Dec 2024 10-K 12 Feb 2026 2025 FY
Q4 2023 $44,148,000 +$9,612,000 +28% 31 Dec 2023 10-K 12 Feb 2026 2025 FY
Q4 2022 $34,536,000 +$13,141,000 +61% 31 Dec 2022 10-K 12 Feb 2026 2025 FY
Q4 2021 $21,395,000 +$9,428,000 +79% 31 Dec 2021 10-K 11 Feb 2025 2024 FY
Q4 2020 $11,967,000 +$6,736,000 +129% 31 Dec 2020 10-K 21 Feb 2024 2023 FY
Q4 2019 $5,231,000 +$3,636,000 +228% 31 Dec 2019 10-K 21 Feb 2023 2022 FY
Q4 2018 $1,595,000 +$1,241,000 +351% 31 Dec 2018 10-K 15 Feb 2022 2021 FY
Q4 2017 $354,000 +$191,000 +117% 31 Dec 2017 10-K 16 Feb 2021 2020 FY
Q4 2016 $163,000 +$114,000 +233% 31 Dec 2016 10-K 12 Feb 2020 2019 FY
Q4 2015 $49,000 31 Dec 2015 10-K 25 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.